Showing results (211-220 of 270) with videos related to

Sort By:
Pageof 27
British Journal of Cancer|November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2020
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 SubtypeValentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2023
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studiesFederica Miglietta, Maria Vittoria Dieci, Tommaso Giarratano, et al.
Molecular Diagnosis & Therapy|June 17, 2026
Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid BiopsyFederico Rojo, Valentina Guarneri, Nicola Fusco, et al.
Frontiers in Oncology|July 15, 2021
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated CenterGiulia Pasello, Jessica Menis, Sara Pilotto, et al.
The Oncologist|May 31, 2022
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER StudyMartina Lorenzi, Alessandra Ferro, Fabiana Cecere, et al.
Breast (Edinburgh, Scotland)|June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validationLuisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.
Translational Lung Cancer Research|November 19, 2020
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancerIlaria Attili, Laura Bonanno, Niki Karachaliou, et al.
Journal of the National Cancer Institute|July 31, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Claudio Vernieri, Lorenzo Nicolè, et al.
Nature Medicine|September 13, 2024
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trialNadia Harbeck, Eva Ciruelos, Guy Jerusalem, et al.
Pageof 27